NCT07069595: PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
- State
- Under way
- Phase
- Phase 2
- People
- 78 planned
- Started
- 26 Feb 2026
- Primary completion
- 1 Nov 2031
- Arms
- Patients with higher residual cancer burden
- Results
- None posted
- 16 Jul 2025: Trial registered
- 26 Feb 2026: Trial started